pubmed-article:8207821 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C0019381 | lld:lifeskim |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C0040649 | lld:lifeskim |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C1948023 | lld:lifeskim |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C0013879 | lld:lifeskim |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C0205224 | lld:lifeskim |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:8207821 | lifeskim:mentions | umls-concept:C1504308 | lld:lifeskim |
pubmed-article:8207821 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:8207821 | pubmed:dateCreated | 1994-7-13 | lld:pubmed |
pubmed-article:8207821 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:abstractText | The p41 DNA-binding protein of human herpesvirus 6 is an apparent processivity factor important for viral DNA replication. The p41 promoter was characterized to understand how this processivity factor is regulated. A single transcription start site and a functional TATA box are located 48 and 74 bp, respectively, upstream of the start codon. A reporter construct containing 1,027 bp of the sequence upstream of the p41 start codon was inactive in uninfected T cells but functioned as a strong promoter in human herpesvirus 6-infected cells. Mutational analysis identified a 21-bp element (the EA site) which is located at -73 to -52 bp relative to the transcription start site and is essential for promoter activity. The ability of the EA site to stimulate transcription optimally appears to be strictly dependent upon its distance from the p41 basal promoter. The EA site contains three overlapping sequences, a CAAT-enhancer-binding protein (C/EBP) transcription factor recognition site and two repeat elements. Mobility shift assays using the EA site identified four binding activities (C1 to C4). C1 and C2 are present in both uninfected and infected cells and do not contain C/EBP factors. In infected cells, point mutation of the EA site abrogates C1 and C2 binding activities and destroys transcriptional activity of the p41 promoter. C3 and C4 are present in uninfected cells only and were found to contain C/EBP factors. These findings indicate that in infected cells, transcriptional stimulation of the p41 promoter by the EA site requires C1 and C2 binding activities. These results further suggest that transcriptional activity may also depend upon the elimination of C3 and C4 binding activities. | lld:pubmed |
pubmed-article:8207821 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:language | eng | lld:pubmed |
pubmed-article:8207821 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8207821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8207821 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8207821 | pubmed:month | Jul | lld:pubmed |
pubmed-article:8207821 | pubmed:issn | 0022-538X | lld:pubmed |
pubmed-article:8207821 | pubmed:author | pubmed-author:RicciardiR... | lld:pubmed |
pubmed-article:8207821 | pubmed:author | pubmed-author:ThompsonJ RJR | lld:pubmed |
pubmed-article:8207821 | pubmed:author | pubmed-author:AgulnickA DAD | lld:pubmed |
pubmed-article:8207821 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8207821 | pubmed:volume | 68 | lld:pubmed |
pubmed-article:8207821 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8207821 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8207821 | pubmed:pagination | 4478-85 | lld:pubmed |
pubmed-article:8207821 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:meshHeading | pubmed-meshheading:8207821-... | lld:pubmed |
pubmed-article:8207821 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8207821 | pubmed:articleTitle | A novel cis element essential for stimulated transcription of the p41 promoter of human herpesvirus 6. | lld:pubmed |
pubmed-article:8207821 | pubmed:affiliation | Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia 19104. | lld:pubmed |
pubmed-article:8207821 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8207821 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8207821 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8207821 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8207821 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8207821 | lld:pubmed |